CD4 and AIDS: Although chronically infected participants had significantly lower nadir CD4+ T cell counts, higher rates of lifetime AIDS diagnoses, and longer estimated days to first initiation of ART than recently infected participants, EDI groups did not differ with respect to current CD4+ T cell counts.